Kestrel Group Reports Third Quarter 2025 Financial Results

Go back to Kestrel Group Reports Third Quarter 2025 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 8.48 -0.31 (3.53%)
Previous Close $8.79    52 Week High $14.26 
Open $9.30    52 Week Low $7.18 
Day High $9.32    P/E 24.94 
Day Low $8.48    EPS $0.34 
Volume 15,917